Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine-Reference-Cited by-同舟云学术

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

Published:2021-02-04 Issue:5 Volume:384 Page:403-416
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Baden Lindsey R.¹,El Sahly Hana M.¹^ORCID,Essink Brandon¹,Kotloff Karen¹,Frey Sharon¹,Novak Rick¹,Diemert David¹,Spector Stephen A.¹,Rouphael Nadine¹,Creech C. Buddy¹,McGettigan John¹,Khetan Shishir¹,Segall Nathan¹,Solis Joel¹,Brosz Adam¹,Fierro Carlos¹,Schwartz Howard¹,Neuzil Kathleen¹,Corey Lawrence¹^ORCID,Gilbert Peter¹,Janes Holly¹,Follmann Dean¹,Marovich Mary¹,Mascola John¹,Polakowski Laura¹,Ledgerwood Julie¹,Graham Barney S.¹,Bennett Hamilton¹,Pajon Rolando¹,Knightly Conor¹,Leav Brett¹,Deng Weiping¹,Zhou Honghong¹,Han Shu¹,Ivarsson Melanie¹,Miller Jacqueline¹,Zaks Tal¹

Affiliation:

1. From Brigham and Women’s Hospital (L.R.B.), Boston, and Moderna, Cambridge (H.B., R.P., C.K., B.L., W.D., H.Z., S.H., M.I., J. Miller, T.Z.) — both in Massachusetts; Baylor College of Medicine (H.M.E.S.) and Centex Studies (J.S.) — both in Houston; Meridian Clinical Research, Savannah (B.E., S.K., A.B.), and Emory University (N.R.) and Atlanta Clinical Research Center (N.S.), Atlanta — all in Georgia; University of Maryland School of Medicine, Baltimore (K.K., K.N.), and National Institute of Allergy and...

Funder

National Institute of Allergy and Infectious Diseases

Federal funds from the Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa2035389

Cited by 8466 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 Vaccination and Ocular Adverse Events: A Self-Controlled Case Series Study From the Entire South Korean Population;American Journal of Ophthalmology;2025-01

2. Vaccine efficacy, safety, and regulatory controls;mRNA Therapeutics;2025

3. Viral Infections: Overview with a focus on Prevention of Transmission;International Encyclopedia of Public Health;2025

4. Worth a shot? The political economy of government responsiveness in times of crisis;World Development;2024-12

5. Sparsely PEGylated poly(beta-amino ester) polyplexes enhance antigen specific T-cell response of a bivalent SARS-CoV-2 DNA vaccine;Biomaterials;2024-12